More recently, Lambe et al examined PN dependency and growth over 48 weeks of therapy with GLP‐2 (0.05 mg/kg/day) in children with SBS (N = 25) who had reached a plateau in intestinal adaptation.30 Here, GCG is linked to macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss.